Introduction
Ethylene Oxide (EO) sterilization remains a preferred method for medical devices incompatible with radiation or moist heat. However, it’s a top source ofquality management system deficiencies during FDA/ISO audits. Proactively addressing these non-conformities is essential forsterile medical device registration and compliance.

I. Sterilization Validation Failures

Critical gaps in proving process effectiveness:

  • ؟Undefined processes: Missing sterilization parameters in design documentation.
  • ؟SAL omissions: Sterility Assurance Level (SAL) not specified in reports.
  • ؟Unapproved/incomplete reports: Lack evaluative conclusions or raw test data.
  • ؟Software validation gaps: No data for sterilizer software systems.
  • ؟Revalidation issues: Triggers/cycles undefined; changes made without revalidation.
  • ؟Parameter mismatches: Conflicts between protocols, records, or physical equipment IDs.
  • ؟Aeration flaws: Unclear conditions/duration in documentation.

؟Fix: Align with ISO 11135. Validate ALL critical parameters (load configs, BI placement, gas dosage).

II. Warehouse & Storage Risks

EO safety and material control violations:

  • ؟Poor facility controls: Weeds, stagnant water, or debris in production zones.
  • ؟Inadequate aeration: Missing/undersized rooms; poor ventilation or exhaust.
  • ??Unsafe EO storage: Non-dedicated zones; cylinders stored haphazardly without:
    • Temperature/humidity monitoring
    • Fire controls or leak detection
  • ؟Material management gaps: Unlabeled sterile items; no environmental monitors.

III. Sterilization Process Control Errors

Deviations during execution:

  • ؟Poor traceability: Ambiguous batch numbering; missing device IDs/logs.
  • ??Missing critical parameters in logs:
    • Gas injection time, EO dosage, vacuum cycles
    • BI lot numbers, temperature/humidity data
  • ؟Uncontrolled deviations: Parameters not matching validated specs or work instructions.
  • ؟Missing safety systems: No gas leak detectors or load diagrams in SOPs.

IV. Residual Control Oversights

Patient safety risks from EO residues:

  • ؟Missing validation: No data supporting residue removal methods.
  • ؟Incomplete records: Raw test data or equipment IDs absent.
  • ??Non-compliant limits: Unsubstantiated EO residue thresholds.

V. Documentation & Personnel Gaps

Systemic compliance weaknesses:

  • ؟Uncontrolled documents: Obsolete SOPs; unnumbered forms; unsigned records.
  • ???Equipment neglect: Using faulty sterilizers; unlabeled piping; expired calibrations.
  • ???Untrained staff: No competency assessments for sterilization operators.

VI. Supply Chain & Sales Issues

Traceability breakdowns:

  • ؟Incomplete sales records: Missing batch IDs, expiration dates, or client details.
  • ؟Expired contracts: EO service agreements not renewed.
  • ؟Sample deviations: Retained sample quantities mismatched with procedures.

اگر آپ مزید جاننا چاہتے ہیں

فون:+8619975258603

ای میل:hayley@hzbocon.com

مقامی سائٹ: کمرہ 1202، Caitong Zhongxin، Xiasha ڈسٹرکٹ، Hangzhou City، Zhejiang Province، China

ویب سائٹ:hzbocon.comzjbocon.com

اوپر سے سکرول کریں